Lexicon Announces Publication Of TELESTAR Study Results For Telotristat Ethyl In The Journal Of Clinical Oncology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/10/2026

1. SPY
2. USO
3. META
4. MSFT
5. MU
6. COST
7. IONS
8. AVAV
9. SKHY
10. ORCL

Go back to Lexicon Announces Publication Of TELESTAR Study Results For Telotristat Ethyl In The Journal Of Clinical Oncology

Lexicon Pharma (LXRX) Tops Q3 EPS by 14c

November 1, 2016 8:15 AM EDT

Lexicon Pharma (NASDAQ: LXRX) reported Q3 EPS of ($0.35), $0.14 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $27.7 million versus the consensus estimate of $9.68 million.

For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.

... More